1-20 of 28
Ann-Lii Cheng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

Open Access
Subject Area:
Oncology
Derek De-Rui Huang, Bin-Chi Liao, Wei-Hsun Hsu, Ching-Yao Yang, Yen-Ting Lin, Shang-Gin Wu, Tzu-Hsiu Tsai, Kuan-Yu Chen, Chao-Chi Ho, Wei-Yu Liao, Jin-Yuan Shih, Chong-Jen Yu, James Chih-Hsin Yang, Ann-Lii Cheng, Ying-Chun Shen
Journal: Oncology
Oncology (2024) 102 (4): 318–326.
https://doi.org/10.1159/000534350
Published Online: 29 September 2023
View articletitled, Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
Open the PDF for Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors in another window
Journal Articles

Cyclin-Dependent Kinase 9 Inhibition as a Potential Treatment for Hepatocellular Carcinoma

Available to Purchase
Subject Area:
Oncology
Yu-Yun Shao, Hung-Wei Hsu, Rita Robin Wo, Han-Yu Wang, Ann-Lii Cheng, Chih-Hung Hsu
Journal: Oncology
Oncology (2022) 100 (11): 602–611.
https://doi.org/10.1159/000526978
Published Online: 14 September 2022
View articletitled, Cyclin-Dependent Kinase 9 Inhibition as a Potential Treatment for Hepatocellular Carcinoma
Open the PDF for Cyclin-Dependent Kinase 9 Inhibition as a Potential Treatment for Hepatocellular Carcinoma in another window
Journal Articles

ICOS-Positive Regulatory T Cells in Hepatocellular Carcinoma: The Perspective from Digital Pathology Analysis

Available to Purchase
Subject Area:
Oncology
Li-Chun Lu, Cecilia Deantonio, Cintia C. Palu, Yi-Hsuan Lee, Laura S. Mitchell, Marianne Cowan, Matthew Corser, Lorcan Sherry, Ann-Lii Cheng, Sonia Quaratino, Yu-Yun Shao, Richard C.A. Sainson, Chih-Hung Hsu
Journal: Oncology
Oncology (2022) 100 (8): 419–428.
https://doi.org/10.1159/000525239
Published Online: 16 June 2022
View articletitled, ICOS-Positive Regulatory T Cells in Hepatocellular Carcinoma: The Perspective from Digital Pathology Analysis
Open the PDF for ICOS-Positive Regulatory T Cells in Hepatocellular Carcinoma: The Perspective from Digital Pathology Analysis in another window
Journal Articles

CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer

Available to Purchase
Subject Area:
Oncology
Kuo-Hsing Chen, Liang-In Lin, Li-Hui Tseng, Yu-Lin Lin, Jau-Yu Liau, Jia-Huei Tsai, Jin-Tung Liang, Been-Ren Lin, Ann-Lii Cheng, Kun-Huei Yeh
Journal: Oncology
Oncology (2019) 96 (3): 156–163.
https://doi.org/10.1159/000493387
Published Online: 12 December 2018
View articletitled, CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer
Open the PDF for CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer in another window
Journal Articles

Treatment Efficacy Differences of Sorafenib for Advanced Hepatocellular Carcinoma: A Meta-Analysis of Randomized Clinical Trials

Available to Purchase
Subject Area:
Oncology
Yu-Yun Shao, Wen-Yi Shau, Soa-Yu Chan, Li-Chun Lu, Chih-Hung Hsu, Ann-Lii Cheng
Journal: Oncology
Oncology (2015) 88 (6): 345–352.
https://doi.org/10.1159/000369559
Published Online: 07 January 2015
View articletitled, Treatment Efficacy Differences of Sorafenib for Advanced Hepatocellular Carcinoma: A Meta-Analysis of Randomized Clinical Trials
Open the PDF for Treatment Efficacy Differences of Sorafenib for Advanced Hepatocellular Carcinoma: A Meta-Analysis of Randomized Clinical Trials in another window
Journal Articles

β-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma

Available to Purchase
Subject Area:
Oncology
Li-Chun Lu, Yu-Yun Shao, Yi-Hsuan Lee, Min-Shu Hsieh, Chi-Huang Hsiao, Hsiao-Hui Lin, Hsiang-Fong Kao, Yu-Yi Ma, Feng-Chu Yen, Ann-Lii Cheng, Chih-Hung Hsu
Journal: Oncology
Oncology (2014) 87 (3): 159–166.
https://doi.org/10.1159/000362821
Published Online: 08 July 2014
View articletitled, β-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma
Open the PDF for β-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma in another window
Journal Articles

Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer

Available to Purchase
Subject Area:
Oncology
Ying-Chun Shen, Chung-Pin Li, Chia-Jui Yen, Chiun Hsu, Yu-Lin Lin, Zhong-Zhe Lin, Li-Tzong Chen, Wu-Chou Su, Yee Chao, Kun-Huei Yeh, Ann-Lii Cheng
Journal: Oncology
Oncology (2014) 87 (2): 104–113.
https://doi.org/10.1159/000362671
Published Online: 04 July 2014
View articletitled, Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer
Open the PDF for Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer in another window
Journal Articles

The Germline BIM Deletion Polymorphism Is Not Associated with the Treatment Efficacy of Sorafenib in Patients with Advanced Hepatocellular Carcinoma

Available to Purchase
Subject Area:
Oncology
Yu-Yun Shao, Yung-Lin Chang, Chung-Yi Huang, Chih-Hung Hsu, Ann-Lii Cheng
Journal: Oncology
Oncology (2013) 85 (5): 312–316.
https://doi.org/10.1159/000356019
Published Online: 09 November 2013
View articletitled, The Germline BIM Deletion Polymorphism Is Not Associated with the Treatment Efficacy of Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Open the PDF for The Germline BIM Deletion Polymorphism Is Not Associated with the Treatment Efficacy of Sorafenib in Patients with Advanced Hepatocellular Carcinoma in another window
Journal Articles

Nuclear Expression of Glioma-Associated Oncogene Homolog 1 and Nuclear Factor-κB Is Associated with a Poor Prognosis of Pancreatic Cancer

Available to Purchase
Subject Area:
Oncology
Shih-Hung Yang, Chih-Hung Hsu, Jen-Chieh Lee, Yu-Wen Tien, Sung-Hsin Kuo, Ann-Lii Cheng
Journal: Oncology
Oncology (2013) 85 (2): 86–94.
https://doi.org/10.1159/000353452
Published Online: 16 July 2013
View articletitled, Nuclear Expression of Glioma-Associated Oncogene Homolog 1 and Nuclear Factor-κB Is Associated with a Poor Prognosis of Pancreatic Cancer
Open the PDF for Nuclear Expression of Glioma-Associated Oncogene Homolog 1 and Nuclear Factor-κB Is Associated with a Poor Prognosis of Pancreatic Cancer in another window
Journal Articles

Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study

Available to Purchase
Subject Area:
Oncology
Chih-Hung Hsu, Yoon Koo Kang, Tsai-Shen Yang, Chia-Tung Shun, Yu-Yun Shao, Wu-Chou Su, Jennifer Sandoval-Tan, Tzeon-Jye Chiou, Kate Jin, Chiun Hsu, Ann-Lii Cheng
Journal: Oncology
Oncology (2013) 85 (1): 44–52.
https://doi.org/10.1159/000350841
Published Online: 04 July 2013
View articletitled, Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study
Open the PDF for Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study in another window
Journal Articles

The Aurora Kinases Inhibitor VE-465 is a Novel Treatment for Glioblastoma Multiforme

Available to Purchase
Subject Area:
Oncology
Pei-Ying Lee, Chi-Long Chen, Zhong-Zhe Lin, Ann-Lii Cheng, Edmund I-Tsuen Chen, Jacqueline Whang-Peng, Chi-Ying F. Huang
Journal: Oncology
Oncology (2013) 84 (6): 326–335.
https://doi.org/10.1159/000347021
Published Online: 27 April 2013
View articletitled, The Aurora Kinases Inhibitor VE-465 is a Novel Treatment for Glioblastoma Multiforme
Open the PDF for The Aurora Kinases Inhibitor VE-465 is a Novel Treatment for Glioblastoma Multiforme in another window
Journal Articles

A Critical Evaluation of the Preventive Effect of Antiviral Therapy on the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C or B: A Novel Approach by Using Meta-Regression

Available to Purchase
Subject Area:
Oncology
Ying-Chun Shen, Chiun Hsu, Chia-Chi Cheng, Fu-Chang Hu, Ann-Lii Cheng
Journal: Oncology
Oncology (2012) 82 (5): 275–289.
https://doi.org/10.1159/000337293
Published Online: 27 April 2012
View articletitled, A Critical Evaluation of the Preventive Effect of Antiviral Therapy on the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C or B: A Novel Approach by Using Meta-Regression
Open the PDF for A Critical Evaluation of the Preventive Effect of Antiviral Therapy on the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C or B: A Novel Approach by Using Meta-Regression in another window
Journal Articles

Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma

Available to Purchase
Subject Area:
Oncology
Yu-Yun Shao, Zhong-Zhe Lin, Chiun Hsu, Kuan-Der Lee, Chi-Huang Hsiao, Yen-Shen Lu, Chien-Chung Huang, Yin-Chun Shen, Chih-Hung Hsu, Ann-Lii Cheng
Journal: Oncology
Oncology (2012) 82 (1): 59–66.
https://doi.org/10.1159/000336126
Published Online: 04 February 2012
View articletitled, Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma
Open the PDF for Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma in another window
Journal Articles

Targeting Fibroblast Growth Factor Receptor Signaling in Hepatocellular Carcinoma

Available to Purchase
Subject Area:
Oncology
Ann-Lii Cheng, Ying-Chun Shen, Andrew X. Zhu
Journal: Oncology
Oncology (2012) 81 (5-6): 372–380.
https://doi.org/10.1159/000335472
Published Online: 20 January 2012
View articletitled, Targeting Fibroblast Growth Factor Receptor Signaling in Hepatocellular Carcinoma
Open the PDF for Targeting Fibroblast Growth Factor Receptor Signaling in Hepatocellular Carcinoma in another window
Journal Articles

Asian Consensus Workshop Report: Expert Consensus Guideline for the Management of Intermediate and Advanced Hepatocellular Carcinoma in Asia

Available to Purchase
Subject Area:
Oncology
Kwang-Hyub Han, Masatochi Kudo, Sheng-Long Ye, Jong Young Choi, Roonni Tung-Ping Poon, Jinsil Seong, Joong-Won Park, Takafumi Ichida, Jin Wook Chung, Pierce Chow, Ann-Lii Cheng
Journal: Oncology
Oncology (2011) 81 (Suppl. 1): 158–164.
https://doi.org/10.1159/000333280
Published Online: 22 December 2011
View articletitled, Asian Consensus Workshop Report: Expert Consensus Guideline for the Management of Intermediate and Advanced Hepatocellular Carcinoma in Asia
Open the PDF for Asian Consensus Workshop Report: Expert Consensus Guideline for the Management of Intermediate and Advanced Hepatocellular Carcinoma in Asia in another window
Journal Articles

Inferior Survival of Advanced Pancreatic Cancer Patients Who Received Gemcitabine-Based Chemotherapy but Did Not Participate in Clinical Trials

Available to Purchase
Subject Area:
Oncology
Shih-Hung Yang, Yu-Hsuan Kuo, Yu-Wen Tien, Chiun Hsu, Chih-Hung Hsu, Sung-Hsin Kuo, Ann-Lii Cheng
Journal: Oncology
Oncology (2011) 81 (3-4): 143–150.
https://doi.org/10.1159/000330817
Published Online: 19 October 2011
View articletitled, Inferior Survival of Advanced Pancreatic Cancer Patients Who Received Gemcitabine-Based Chemotherapy but Did Not Participate in Clinical Trials
Open the PDF for Inferior Survival of Advanced Pancreatic Cancer Patients Who Received Gemcitabine-Based Chemotherapy but Did Not Participate in Clinical Trials in another window
Journal Articles

High Circulating Endothelial Progenitor Levels Associated with Poor Survival of Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib Combined with Metronomic Chemotherapy

Available to Purchase
Subject Area:
Oncology
Yu-Yun Shao, Zhong-Zhe Lin, Te-Jung Chen, Chiun Hsu, Ying-Chun Shen, Chih-Hung Hsu, Ann-Lii Cheng
Journal: Oncology
Oncology (2011) 81 (2): 98–103.
https://doi.org/10.1159/000331684
Published Online: 04 October 2011
View articletitled, High Circulating Endothelial Progenitor Levels Associated with Poor Survival of Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib Combined with Metronomic Chemotherapy
Open the PDF for High Circulating Endothelial Progenitor Levels Associated with Poor Survival of Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib Combined with Metronomic Chemotherapy in another window
Journal Articles

Primary T Cell Leptomeningeal Lymphoma – Successful Treatment with Systemic Chemotherapy

Available to Purchase
Subject Area:
Oncology
Kun-Huei Yeh, Ann-Lii Cheng, Hwei-Fang Tien
Journal: Oncology
Oncology (1995) 52 (6): 501–504.
https://doi.org/10.1159/000227519
Published Online: 30 June 2009
View articletitled, Primary T Cell Leptomeningeal Lymphoma – Successful Treatment with Systemic Chemotherapy
Open the PDF for Primary T Cell Leptomeningeal Lymphoma – Successful Treatment with Systemic Chemotherapy in another window
Journal Articles

Angioimmunoblastic Lymphadenopathy with Dysproteinemia – Lack of a Prognostic Value of Clear Cell Morphology

Available to Purchase
Subject Area:
Oncology
Hui-Ju Ch’ang, Ih-Jen Su, Chi-Long Chen, I-Pieng Chiang, Yao-Chang Chen, Chiu-Hwa Wang, Ann-Lii Cheng
Journal: Oncology
Oncology (1997) 54 (3): 193–198.
https://doi.org/10.1159/000227687
Published Online: 30 June 2009
View articletitled, Angioimmunoblastic Lymphadenopathy with Dysproteinemia – Lack of a Prognostic Value of Clear Cell Morphology
Open the PDF for Angioimmunoblastic Lymphadenopathy with Dysproteinemia – Lack of a Prognostic Value of Clear Cell Morphology in another window
Journal Articles

Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin in the Treatment of Advanced Gastric Cancers: An Effective and Low-Toxic Regimen for Patients with Poor General Condition

Available to Purchase
Subject Area:
Oncology
Chih-Hung Hsu, Kun-Huei Yeh, Li-Tzong Chen, Jacqueline Ming Liu, Chang-Ming Jan, Jaw-Town Lin, Yao-Chang Chen, Ann-Lii Cheng
Journal: Oncology
Oncology (1997) 54 (4): 275–280.
https://doi.org/10.1159/000227702
Published Online: 30 June 2009
View articletitled, Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin in the Treatment of Advanced Gastric Cancers: An Effective and Low-Toxic Regimen for Patients with Poor General Condition
Open the PDF for Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin in the Treatment of Advanced Gastric Cancers: An Effective and Low-Toxic Regimen for Patients with Poor General Condition in another window